Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


Sarepta Therapeutics Initiates its EMBARK Study of SRP-9001 to Treat Duchenne Muscular Dystrophy


Benzinga | Oct 4, 2021 07:11AM EDT

Sarepta Therapeutics Initiates its EMBARK Study of SRP-9001 to Treat Duchenne Muscular Dystrophy






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-5
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC